Techsomed logo — Unlocking the true potential of Image Guided Ablation Therap...

Techsomed

Unlocking the true potential of Image Guided Ablation Therapy

Founded 2012 Israel Israel 29 employees Series B Total: $9.60M Biotechnology, Health Care

General Information

Company Name Techsomed
Founded Year 2012
Location Israel Israel +1
Employees 29
Industries Biotechnology, Health Care
Funding Stage Series B
Social

Get notified when Techsomed moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Techsomed

Techsomed is an Israeli-based medical device company, founded in 2012, with the slogan "Unlocking the true potential of Image Guided Ablation Therapy." The company is focused on developing ultrasound-based real-time monitoring systems for thermal ablation procedures, addressing the limitations of the current market. Thermal ablation has various applications including tumor destruction, heart arrhythmia, and blood pressure treatments. Despite its significant market size, the lack of real-time monitoring capabilities has led to high failure rates in these procedures. The last investment round of $7.00M was secured through a Series B funding at 03 March 2021, with participation from notable investors such as Axil Capital, CoBro Ventures, NextLeap Ventures, Radianx Capital, Yongjin Group, Magna Capital Partners, and Johnson & Johnson Innovation – JJDC. Techsomed's innovative technology aims to offer added value to patients, physicians, and insurance companies by mitigating the high failure rate associated with these minimally invasive and cost-effective procedures. With its focus on biotechnology and health care industries, the company's potential to disrupt the thermal ablation market and address critical unmet needs makes it an attractive prospect for venture capital investment.

Taxonomy: medical device, ultrasound technology, real-time monitoring, thermal ablation, tumor destruction, heart arrhythmia, blood pressure treatment, minimally invasive procedures, Israeli company, innovation, physician support, insurance industry, startup

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 7
Investor Investor Investor Investor Investor Investor
•••• ••••
03 Mar 2021
Venture Round •••••• 3
Investor
•••• ••••
30 May 2019

Techsomed Alternatives & Competitors

Techsomed vs
EtaPRO LLC
EtaPRO LLC United States

EtaPRO® is a real-time monitoring platform for keeping equipment and facilities running efficiently...

46 employees
Automation
Techsomed vs
Theromics Inc.
Theromics Inc. United States

Next-generation thermal accelerant technology for enhanced ablation and precision intratumoral drug...

Grant
11 employees
Biotechnology, Health Care
Techsomed vs

Incision-Free, Ablative Interventions with Vision

Post Ipo Equity
184 employees
Health Care, Medical Devices

FAQ About Techsomed

Unlocking the true potential of Image Guided Ablation Therapy
Techsomed was founded in 2012.
Techsomed is headquartered in Israel.
Techsomed operates in the following industries: Biotechnology, Health Care.
Techsomed has approximately 29 employees.
Techsomed has completed 2 funding rounds, raising a total of $9.60M. The latest funding stage is Series B.
Top alternatives and competitors to Techsomed include EtaPRO LLC, Theromics Inc., Profound Medical Inc., AEGEA Medical, Precision Cardiovascular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Techsomed and EtaPRO LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Techsomed and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy